Inrad
Private Company
Funding information not available
Overview
Founded in 1981, Inrad is an established, revenue-generating medical device manufacturer operating in the diagnostics sector. The company develops and commercializes a portfolio of interventional products, including the Trilogy breast tissue markers, PreciseCore biopsy device, and SampleMaster ultrasound needles, all engineered for precision and visibility under imaging modalities. With headquarters in Northvale, USA, and a manufacturing/office facility in Kentwood, Michigan, Inrad serves interventional radiologists and surgeons, emphasizing quality, innovation, and direct customer engagement. As a private company, it maintains a focused business model on designing, manufacturing, and selling disposable diagnostic devices.
Technology Platform
Design and manufacturing of advanced materials and components for enhanced medical imaging visibility and procedural precision, including HiLiter® ultrasound enhancement technology and multi-modality visible markers.
Opportunities
Risk Factors
Competitive Landscape
Inrad competes in the interventional radiology device market against major players like Hologic, BD (Bard), Merit Medical, and Argon Medical, as well as other specialized manufacturers. Its competitive differentiation is based on specific product features like the 'no-throw' biopsy mechanism, multi-modality visible markers, and proprietary ultrasound enhancement, rather than scale or breadth of portfolio.